News

2025.02.12
Genomtec to issue shares to raise funds to support commercialization of projects

2025.01.28
Genomtec has filed a second patent application for the OncoSNAAT oncology project

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

Archive

2023.03.29

Presentation – Genomtec’s development plans and the status of the M&A process

We invite you to watch the webinar and chat with Genomtec’s Management Board, which took place on Strefa Inwestorów on Wednesday, March 29. ...
Read
2023.03.22

Webinar with the Management Board of Genomtec

A webinar with Genomtec Management Board organized by the Warsaw Stock Exchange will be held on Friday, March 24, at 4:00 pm. Link to the ...
Read
2023.03.21

Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent

According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ ...
Read
2023.03.07

Puls Biznesu: Genomtec wants to strengthen with a share issue

In February, the company announced plans for a share issue of up to 1.64 million shares, which will represent 14 percent of the company’s ...
Read
2023.02.28

Genomtec S.A. intensifies M&A process

The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the ...
Read
2023.02.16

Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange

On 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange Video from the debut: ...
Read

Archive